Advancing the Discovery & Development of Peptide Drugs with Novel Screening, Chemistry & Formulation Methods to Improve Permeability, Bioavailability & Efficacy Across Diseases
The peptide therapeutics field is entering a defining new era as breakthroughs in oral delivery, macrocyclic peptidedesign, AI-enabled discovery and scalable manufacturing rapidly expand what these molecules can achieve. Landmark milestones, including the approval of the world's first once-daily oral PCSK9 inhibitor macrocyclic peptide and a wave of billion-dollar industry partnerships, signal a major shift from promise to commercial reality, creating unprecedented opportunities across pharma and biotech.
The inaugural Peptide-Based Therapeutics Summit Europe is the only European forum dedicated to bringing together the scientists and innovators advancing peptide therapeutics from discovery through to commercialisation. Designed specifically for peptide discovery, medicinal chemistry, formulation, delivery, CMC and manufacturing leaders, the summit provides a unique platform to benchmark cutting-edge science, address shared technical challenges and accelerate programme success.
Join 80+ senior experts from leading pharma, biotech and academia to explore the latest advances in AI-driven peptide design, oral bioavailability, targeted delivery, predictive screening, manufacturing scale-up and regulatory strategy. Through interactive workshops, scientific presentations, panel discussions and dedicated networking opportunities, you'll gain practical insights, build valuable collaborations and leave equipped to advance the next generation of peptide therapeutics.
Attending Companies Include